PK and Safety of Beclomethasone Dipropionate via Breath-Actuated Inhaler and Metered-Dose Inhaler
- Study Title
- A Study to Investigate the Pharmacokinetics and Safety of Beclomethasone Dipropionate Administered by Breath-Actuated Inhaler and Metered-Dose Inhaler in Healthy Adults
- Teva Identifier
- BDB-AS-101
- ClinicalTrials.gov Identifier
- NCT02030457
- Study Status
- Completed
- Trial Condition(s)
- Pharmacokinetics
- Interventions
- Drug: Beclomethasone dipropionate BAI | Drug: Beclomethasone dipropionate MDI
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult
- Age Range
- 18 Years to 45 Years
- Trial Duration
- 12/01/2013 - 06/01/2014
- Phase
- Phase 1
